Infection Due To Staphylococcus Aureus — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for infection due to staphylococcus aureus. 28 active patents protecting 5 drugs from 5+ originators. First major cliff: 2030. Daily refresh.

5
Approved drugs
28
Active US patents
60/100
Avg vulnerability
—
Annual revenue covered

Originators in Infection Due To Staphylococcus Aureus

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Generic (originally Beecham/GSK) 14 patents ANI Pharmaceuticals 5 patents AbbVie 4 patents Pfizer 3 patents Novartis 2 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating infection due to staphylococcus aureus. Each bar = one year. Y-axis scaled to peak year (7 patents).

3
26
1
27
1
28
7
30
2
31
6
34
5
35
2
36

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Amoxil
amoxicillin
 Generic (originally Beecham/GSK) 14 58 — 2026-12-08
Vancocin
vancomycin
 ANI Pharmaceuticals 5 39 — 2035-11-06
Teflaro
CEFTAROLINE FOSAMIL
 AbbVie 4 61 — 2030-09-21
Cleocin T
CLINDAMYCIN PHOSPHATE
 Pfizer 3 68 — 2026-12-02
Tobi
tobramycin
 Novartis 2 72 — 2028-09-12

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
8299052 Amoxil method of use 85 2027-05-07
9789057 Cleocin T method of use 80 2026-12-02
8778924 Amoxil method of use 80 2026-12-08
8869794 Tobi method of use 75 2028-09-12
11931463 Amoxil method of use 75 2034-02-12
11878011 Amoxil method of use 75 2042-05-27
8247400 Teflaro method of use 73 2031-02-10
8247400 Teflaro method of use 73 2031-02-10
11129896 Cleocin T method of use 70 2036-09-22
10207066 Tobi method of use 68 2030-11-04

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
7977488 Amoxil composition of matter 18 2030-04-10
7977488 Amoxil composition of matter 18 2030-04-10
10849956 Vancocin formulation 25 2035-11-06
11000567 Vancocin formulation 25 2035-11-06
10238606 Amoxil formulation 42 2034-02-12
10039804 Vancocin method of use 45 2035-11-06
10188697 Vancocin method of use 45 2035-11-06
9629861 Teflaro formulation 48 2030-09-21
9629861 Teflaro formulation 48 2030-09-21
11517609 Vancocin method of use 53 2035-11-06

Related